TMS Future Growth
Future criteria checks 0/6
TMS is forecast to grow earnings and revenue by 4.3% and 59.1% per annum respectively while EPS is expected to grow by 5.1% per annum.
Key information
4.3%
Earnings growth rate
5.1%
EPS growth rate
| Biotechs earnings growth | 10.0% |
| Revenue growth rate | 59.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 12 Apr 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 2/28/2027 | 469 | -1,531 | N/A | N/A | 1 |
| 2/28/2026 | N/A | -1,300 | N/A | N/A | 1 |
| 2/28/2025 | N/A | -1,275 | N/A | N/A | 1 |
| 5/31/2024 | N/A | -1,059 | N/A | N/A | N/A |
| 2/29/2024 | N/A | -960 | -825 | -822 | N/A |
| 11/30/2023 | N/A | -671 | N/A | N/A | N/A |
| 8/31/2023 | N/A | -734 | N/A | N/A | N/A |
| 5/31/2023 | N/A | -774 | N/A | N/A | N/A |
| 2/28/2023 | N/A | -860 | -701 | -688 | N/A |
| 2/28/2022 | 1,946 | 1,076 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4891 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 4891 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 4891 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 4891 is forecast to have no revenue next year.
High Growth Revenue: 4891 is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 4891's Return on Equity is forecast to be high in 3 years time